Bipolar Disorder or Schizophrenia |
1.40 |
6 |
3 |
6.7 |
-0.15 |
7.8e-01 |
C14orf153 CERS5 CHMP1A FES NT5C2 SDCCAG8 |
Depressed Affect (Nagel 2018) |
1.18 |
4 |
2 |
4.4 |
0.80 |
2.0e-01 |
ACP2 NR1H3 PTPRJ RP5-1115A15.1 |
Intelligence (Savage-Jansen 2018) |
1.31 |
6 |
4 |
8.9 |
-0.53 |
2.8e-01 |
ACP2 DCAF16 FBXO41 GTF2B MADD NEGR1 |
Neuroticism (Nagel 2018) |
1.13 |
4 |
2 |
4.4 |
0.27 |
7.3e-01 |
ACP2 NR1H3 RP5-1115A15.1 ZNF668 |
Schizophrenia (2018) |
1.37 |
4 |
4 |
8.9 |
-0.58 |
4.2e-01 |
C14orf153 FES NT5C2 SDCCAG8 |
Worry (Nagel 2018) |
1.24 |
5 |
3 |
6.7 |
-0.17 |
7.8e-01 |
CPEB2 NR1H3 NT5C2 PCCB ZNF668 |
Alzheimer’s Disease (in mother) |
1.71 |
5 |
4 |
8.9 |
0.78 |
1.2e-01 |
APOC4 BCAM PVRL2 TOMM40 ZNF668 |
Alzheimer’s Disease (in father) |
1.42 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
APOC4 PVRL2 TOMM40 |
Alzheimer’s Disease (including proxy) |
2.85 |
7 |
6 |
13.3 |
0.43 |
3.4e-01 |
ACE APOC4 BCAM PVRIG PVRL2 TOMM40 ZNF668 |
Crohns Disease (2017) |
1.63 |
8 |
5 |
11.1 |
0.17 |
7.0e-01 |
C5orf56 FNDC4 FUT2 GCKR RP11-373D23.3 TCTA TMBIM1 ZFP36L2 |
Irritable Bowel Disease (IBD) |
1.65 |
10 |
5 |
11.1 |
0.09 |
8.0e-01 |
C5orf56 FNDC4 FUT2 GMEB2 LSP1 OPRL1 PMS2P5 RP11-373D23.3 TMBIM1 ZFP36L2 |
Ulcerative Colitis (UC) |
1.39 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
LSP1 OPRL1 TMBIM1 |
Major Depression (MDD) |
1.24 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
NEGR1 |
Reaction Time |
1.77 |
8 |
6 |
13.3 |
0.86 |
2.8e-03 |
AC003029.1 ALDH2 HECTD4 MAPKAPK5 NAA25 OLA1 SH2B3 TCTA |
Verbal and Numeric Reasoning (VNR) |
1.36 |
5 |
3 |
6.7 |
-0.52 |
3.7e-01 |
ACP2 DCAF16 FBXO41 MADD NEGR1 |
Breast Cancer |
2.00 |
8 |
4 |
8.9 |
-0.51 |
1.6e-01 |
CSK HSPA4 LSP1 RNASEH2C RP11-1055B8.4 SIPA1 SLC4A7 ULK3 |
Prostate Cancer |
1.48 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
TNNT3 |
Age at First Birth |
1.22 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
TCTA |
Body Mass Index (BMI) (2010) |
1.86 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
MAP2K5 NEGR1 STAG3L1 |
Coronary Artery Disease (CAD) |
2.85 |
4 |
3 |
6.7 |
0.99 |
6.4e-03 |
DBR1 EPOR RP11-463M16.4 TCF21 |
Crohns Disease (2012) |
1.39 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
C5orf56 FUT2 TCTA |
Fasting Glucose |
2.75 |
10 |
6 |
13.3 |
-0.97 |
4.9e-06 |
ABHD1 ACP2 DDB2 FNDC4 GCKR GPN1 KRTCAP3 NR1H3 NRBP1 PPM1G |
HbA1C |
1.19 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ADAM1A |
HDL Cholesterol |
3.87 |
15 |
8 |
17.8 |
-0.80 |
2.5e-05 |
ACP2 ADRB1 CTSW DDB2 LPL MADD NR1H3 PIGV PTPRJ RNASEH2C SIPA1 SNRPC SORT1 TOMM40 ZNF259 |
LDL Cholesterol |
9.19 |
24 |
17 |
37.8 |
0.62 |
9.2e-04 |
AC003029.1 ALDH2 APOB BCAM C19orf52 DOCK7 EPOR FUT2 HECTD4 HMGCR LRPPRC MAPKAPK5 NPC1L1 NPEPPS PAFAH1B2 PIGV PVRL2 RPP25 SH2B3 SORT1 SPC24 TOMM40 TXNL4B ZNF259 |
Lupus |
1.49 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SNRPC |
Primary Biliary Cirrhosis |
1.60 |
4 |
1 |
2.2 |
0.98 |
1.6e-02 |
C19orf52 HECTD4 SH2B3 TRIM59 |
Rheumatoid Arthritis |
1.30 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SH2B3 |
Schizophrenia (2014) |
1.38 |
8 |
4 |
8.9 |
-0.29 |
4.8e-01 |
C14orf153 CERS5 CISD2 FES NT5C2 NUCB2 PCCB SDCCAG8 |
Triglycerides |
9.91 |
17 |
15 |
33.3 |
0.89 |
1.0e-06 |
ABHD1 APOB DOCK7 FNDC4 GCKR GPN1 KRTCAP3 LPL NRBF2 NRBP1 PAFAH1B2 PPM1G RGS12 RP11-373D23.3 TXNL4B ZNF259 ZNF668 |
Type 2 Diabetes (T2D) (2012) |
1.72 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CISD2 |
Ulcerative Colitis |
1.50 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
LSP1 TMBIM1 |
Blood Eosinophil Count |
4.42 |
45 |
33 |
73.3 |
0.55 |
3.4e-05 |
AC002558.1 AC003029.1 AC006547.14 ACTR1B ACTRT3 ADAM1A ALDH2 AP3M1 BCAM C14orf153 C19orf52 C5orf56 CD164L2 CERS5 CIRH1A FBF1 FIBP GATAD1 GCKR GNGT2 HECTD4 LPL MAPKAPK5 NAA25 NDUFAF6 NFKBIA NUCB2 PDXK PIGV RNASEH2C RP5-1115A15.1 SH2B3 SIPA1 SMARCE1 SNF8 TCHP THAP9-AS1 TOMM40 TSPY26P UBE2Z ZFP36L2 ZNF259 ZNF652 ZNF668 ZNF831 |
Blood Platelet Count |
3.24 |
78 |
60 |
133.3 |
0.08 |
4.5e-01 |
ABHD1 AC002558.1 AC006547.14 AC091133.1 ADAM1A AP3M1 ARHGAP29 C20orf160 C5orf56 CAMK2N2 CCDC33 CERS5 CFDP1 CLCN6 CLIC4 CRK CSK CTD-2349P21.5 CTSW CWF19L2 DCAF16 DOCK7 ERAP1 FBF1 FIBP FNDC4 FUT2 GATAD1 GCKR GMEB2 GOSR2 GPN1 GTF2B HECTD4 HELLS HMGCR IRAK1BP1 KRTCAP3 LFNG MAPKAPK5 MYO9B NAA25 NELFCD NMT1 NPC1 NPEPPS NRBF2 NRBP1 NUCB2 PAFAH1B2 PCCB PIGV PPM1G PTPRJ RGS12 RHOC RNASEH2C RP11-373D23.3 RPP25 SAV1 SENP1 SH2B3 SIPA1 SLC26A10 SLC4A7 SNF8 SNRPC SNX16 TH1L TMBIM1 TOMM40 TXNL4B UBE2Z YES1 ZC3HC1 ZFP36L2 ZNF259 ZNF318 |
Blood Red Count |
1.90 |
61 |
42 |
93.3 |
0.57 |
3.3e-07 |
AC003029.1 ACTRT3 ADAM1A ALDH2 ANKRD13B ARID3B C14orf153 C15orf17 C20orf160 C4orf22 CCDC33 CLCN6 CLIC4 CLOCK CRK CSK CYB5D1 FBF1 FBRSL1 FES FNDC4 GCKR GMEB2 GOSR2 GTF2B HECTD4 HELLS IPO11 LSP1 MAPKAPK5 MPI MRPS18AP1 NAA25 NCOA1 NDUFAF6 NELFCD NME6 NT5C2 PDIA2 PDXK PTPRJ PVRIG PVRL2 RNASEH2C RP11-332H18.4 RP4-798A10.2 RPP25 SENP1 SH2B3 SIPA1 SLC35F6 SNX15 TCTA TH1L TRIM59 TSPY26P TXNL4B ULK3 USP36 VEGFB ZNF668 |
Blood White Count |
2.98 |
52 |
35 |
77.8 |
0.67 |
1.6e-08 |
ABHD1 AC003029.1 AC006111.1 AC006547.14 ACP2 ADAM1A ALDH2 ANKRD13B ARHGAP29 ARHGAP42 C10orf118 C14orf153 C5orf56 CERS5 CMIP CRK CYB5D1 DCAF16 FBF1 FES FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HELLS HOXC8 KB-1107E3.1 KRTCAP3 LSP1 MAPKAPK5 MOBP NAA25 NFKBIA NPC1 NRBF2 NRBP1 NT5C2 NUCB2 PCCB PLCB1 PPM1G PTPRJ PVRL2 RP11-373D23.3 RP5-1115A15.1 SH2B3 SLC26A6 THADA THAP9-AS1 ZNF652 |
Heel T-Score |
2.00 |
49 |
39 |
86.7 |
-0.11 |
4.1e-01 |
ACP2 ANKRD13B ARHGAP42 ARL14EP ATG7 C14orf153 C20orf160 CMIP CPEB2 CTSW CYB5D1 DCAF16 DDB2 ERAP1 FIBP GATAD1 GTF2B HSPA4 LFNG LOC338758 MADD MAP3K11 MARCH2 NCOA1 NEGR1 NELFCD NFKBIA NMT1 NR1H3 NT5C2 PDE1A PLEKHM2 PTPRJ RNASEH2C RP11-810M2.2 RP4-635E18.7 RP4-798A10.2 RP5-1115A15.1 SIPA1 SORT1 TCTA TH1L THADA TMBIM1 TNFRSF25 TNFSF12 ZNF318 ZNF668 ZNRF3 |
BMI |
2.48 |
58 |
39 |
86.7 |
0.68 |
1.3e-09 |
AC006111.1 AC006547.14 AC091133.1 ACP2 ACTR1B ANKRD13B ARL14EP BZRAP1-AS1 C14orf153 C20orf160 C4orf22 CEP41 CHDH CHP1 CIRH1A CTB-31O20.6 CTSW ERAP1 EXOC4 FAM108C1 FBF1 FIBP FNDC4 GCKR HEY2 HMGCR KB-1107E3.1 MADD MAP2K5 NEGR1 NPC1 NRBF2 NT5C2 OLA1 PCCB PDIA2 PDXDC2P PLEKHM2 PMS2P5 RNF34 RP11-463M16.4 RP11-538P18.2 RP11-613D13.5 RP5-1115A15.1 RPP25 SF3B3 SHISA4 SIPA1 SNF8 SNRPC STAG3L1 TCTA TNFRSF25 TSPY26P TXNL4B UBE2Z USP36 ZNF668 |
Height |
1.94 |
101 |
79 |
175.6 |
-0.53 |
3.2e-09 |
AC002558.1 AC003029.1 AC006111.1 AC091133.1 ACE ACP2 ACTR1B ADRB1 ALDH2 APOC4 ARHGAP42 ARL14EP BZRAP1-AS1 C11orf1 C14orf153 C19orf52 C5orf56 CAMK2N2 CCDC33 CENPW CERS5 CFDP1 CHP1 CLIC4 CLOCK CRK CTD-2349P21.5 CTSW DBR1 DCAF16 DDB2 DYNC2LI1 EPOR FES FNDC4 FUT2 GATAD1 GCKR GLYR1 GNGT2 GOSR2 GPN1 GTF2B HECTD4 HEY2 HRCT1 KRTCAP3 LOC100272146 LPL LSP1 MADD MAP3K11 MAPKAPK5 MARCH2 MET NCOA1 NFKBIA NMT1 NPC1 NPEPPS NRBP1 NT5C2 NUCB2 PDE1A PDXDC2P PIGV PPM1G PTPRJ RGS12 RHOC RP11-1055B8.4 RP11-332H18.4 RP11-373D23.3 RP11-463M16.4 RP11-538P18.2 RP11-810M2.2 RP4-635E18.7 RP4-798A10.2 RP5-1115A15.1 RYK SERTAD4 SH2B3 SIPA1 SLC26A10 SLC35F6 SLC4A7 SNF8 SNRPC SORT1 SPC24 STAG3L1 THEM6 TMBIM1 UBE2Z UPF3A USP36 YEATS4 ZNF259 ZNF318 ZNF652 ZNF831 |
Waist Hip Ratio (WHR) |
1.98 |
35 |
20 |
44.4 |
0.61 |
4.6e-05 |
ADAM1A C22orf31 CEP41 CLOCK CMIP CTD-3032J10.3 CTSW DBR1 FIBP FUT2 HOXC8 HSPA4 LRPPRC MAP3K11 MYO9B NCOA1 OPRL1 PCCB PCNX PTPRJ RNASEH2C RP11-332H18.4 SERTAD4 SIPA1 SLC22A1 SNRPC SWAP70 TBC1D19 TCEA2 TCTA TMBIM1 VEGFB ZFP36L2 ZNF318 ZNRF3 |
Systolic Blood Pressure |
10.58 |
179 |
138 |
306.7 |
0.97 |
3.9e-119 |
AC002558.1 AC003029.1 AC006111.1 AC006547.14 AC091133.1 ACE ACP2 ACTRT3 ADAM1A ADRB1 AGT AKR1B15 ALDH2 AP3M1 APOC4 ARHGAP42 ARID3B ARL14EP ATG7 ATP2B1 BZRAP1-AS1 C10orf118 C11orf1 C15orf17 C1GALT1 C20orf160 C22orf31 C4orf22 CACNB2 CCDC33 CD164L2 CENPW CEP68 CERS5 CFDP1 CHMP1A CHP1 CLCN6 CLIC4 CLOCK CMIP CPEB2 CRK CSK CTB-31O20.6 CTD-3032J10.3 CTSW CWF19L2 CYB5D1 DBR1 DCAF16 DDB2 DYNC2LI1 EIF2A ENPEP ERAP1 EXOC4 FAM108C1 FBF1 FBRSL1 FBXO41 FES FIBP FNDC4 FUT2 GATAD1 GLYR1 GMEB2 GNGT2 GOSR2 GPN1 GTF2B HECTD4 HELLS HIBADH HOXA10 HOXC8 HRCT1 HSPA4 IPO11 IRAK1BP1 KB-1107E3.1 KRTCAP3 LDB3 LFNG LOC338758 LSP1 MADD MAP3K11 MAPKAPK5 MECR MET MPI MRPL35 MRPS18AP1 MYO9B NAA25 NADK NCOA1 NDUFAF6 NELFCD NFKBIA NME6 NMT1 NOC3L NPEPPS NPPA NR1H3 NRBF2 NSUN6 NT5C2 NUCB2 OLA1 OPRL1 PAFAH1B2 PDE1A PDXK PIGV PLCB1 PLEKHM2 PMS2P5 PPM1G PTPRJ RGL3 RGS12 RGS19 RHOC RNASEH2C RNF34 RP11-1055B8.4 RP11-332H18.4 RP11-373D23.3 RP11-463M16.4 RP11-538P18.2 RP4-635E18.7 RP4-798A10.2 RP5-1115A15.1 RPP25 RPS6 RYK SENP1 SF3B3 SH2B3 SIPA1 SLC22A1 SLC26A10 SLC26A6 SLC4A7 SNF8 SNX16 STAG3L1 SWAP70 TBC1D19 TCEA2 TCF21 TCHP TCTA TH1L THADA THAP9-AS1 THEM6 TMBIM1 TNFRSF25 TNFSF12 TNNT3 TPD52L2 TRIM59 UBE2Z ULK3 UPF3A USP36 VEGFB YES1 ZC3HC1 ZFP36L2 ZNF318 ZNF652 ZNF831 ZNRF3 |
Smoking Status |
1.54 |
14 |
0 |
0.0 |
0.60 |
1.7e-02 |
ADAM1A C14orf153 CTSW FAM108C1 FES GNGT2 MAP2K5 MET OLA1 RP11-463M16.4 RP5-1115A15.1 SERTAD4 SNRPC ZNF652 |
Allergy or Eczema |
2.05 |
20 |
7 |
15.6 |
0.12 |
5.8e-01 |
ADAM1A C11orf1 C5orf56 CFDP1 CHP1 CLCN6 GMEB2 HECTD4 KRTCAP3 MPI NEGR1 PLEKHM2 PVRL2 RNF34 RP11-373D23.3 RP5-1115A15.1 SMARCE1 TMBIM1 ULK3 ZNF652 |
Hypothyroidism (self reported) |
2.80 |
13 |
8 |
17.8 |
0.83 |
1.5e-04 |
AC002558.1 AC003029.1 ADAM1A ALDH2 ANKRD13B FUT2 HECTD4 MAPKAPK5 MRPS18AP1 NAA25 RGS12 RP5-1115A15.1 SH2B3 |
Respiratory disease |
1.35 |
7 |
3 |
6.7 |
0.79 |
1.1e-02 |
C5orf56 CHP1 FBF1 GMEB2 NMT1 RP5-1115A15.1 ZNF652 |
Type 2 Diabetes (T2D) (2018) |
2.83 |
18 |
3 |
6.7 |
0.36 |
1.3e-01 |
ACE C1GALT1 CTSW DBR1 FIBP FNDC4 GCKR GPN1 KRTCAP3 NDUFAF6 NRBP1 PPM1G SH2B3 SIPA1 SNF8 TCTA VEGFB ZFP36L2 |
Lung FEV1/FVC ratio |
1.65 |
33 |
19 |
42.2 |
-0.22 |
2.0e-01 |
ANKRD13B ARHGAP42 ATG7 ATP2B1 C1GALT1 C22orf31 CACNB2 CENPW CEP41 CFDP1 CTB-31O20.6 CYB5D1 FUT2 HOXC8 HSPA4 KB-1107E3.1 MARCH2 MET NEGR1 NFKBIA NRBF2 PMS2P5 PVRIG RP11-810M2.2 SHISA4 SORT1 TCF21 THADA THAP9-AS1 TNFRSF25 TSPY26P ZFP36L2 ZNF652 |
Lung FVC |
1.38 |
26 |
15 |
33.3 |
-0.18 |
3.9e-01 |
ANKRD13B C1GALT1 C5orf56 CHP1 DBR1 DCAF16 GMEB2 HECTD4 HOXA10 HOXC8 HSPA4 MAP2K5 NCOA1 NPC1 NRBF2 OPRL1 PVRL2 RGS12 RP11-332H18.4 RP11-538P18.2 RP11-613D13.5 SF3B3 SNRPC TCEA2 TCF21 ZNF668 |
Neuroticism |
1.19 |
6 |
3 |
6.7 |
-0.28 |
5.9e-01 |
MAP2K5 NR1H3 NT5C2 PCCB RP5-1115A15.1 ZNF668 |
Chronotype (morning person) |
1.51 |
6 |
1 |
2.2 |
0.98 |
2.9e-05 |
AC003029.1 ACP2 MADD MAPKAPK5 NAA25 RP11-810M2.2 |
Hair Pigment |
0.76 |
42 |
29 |
64.4 |
0.02 |
8.7e-01 |
AC003029.1 AC006547.14 ACP2 ALDH2 ATP2B1 C14orf153 C20orf160 C22orf31 C4orf22 CHMP1A CLOCK CTSW DBR1 DDB2 FES FIBP FNDC4 GOSR2 GPN1 HECTD4 KRTCAP3 LOC100272146 MADD MAP3K11 MAPKAPK5 NPEPPS NRBP1 NUCB2 PCNX PIGV PPM1G RNASEH2C RP11-373D23.3 RP4-798A10.2 RP5-1115A15.1 SH2B3 SIPA1 SNX15 TSPY26P ZFP36L2 ZNF831 ZNRF3 |
Tanning |
0.97 |
10 |
6 |
13.3 |
-0.28 |
4.1e-01 |
CHMP1A FNDC4 GCKR GPN1 HECTD4 NRBF2 NRBP1 PPM1G SH2B3 TSPY26P |
Hand grip strength (left) |
1.20 |
3 |
1 |
2.2 |
-0.86 |
1.4e-01 |
C5orf56 DCAF16 LRPPRC |
Number of treatments/medications taken |
4.17 |
15 |
6 |
13.3 |
0.97 |
2.9e-10 |
ACE ADAM1A ARHGAP42 CHP1 CISD2 DCAF16 FAM108C1 FBXO41 HECTD4 SERTAD4 SH2B3 SORT1 YEATS4 ZNF652 ZNF831 |
Sensitivity / hurt feelings |
1.21 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SNF8 |
Hearing difficulty/problems: Yes |
1.20 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
AP3M1 ZNF318 |
Relative age of first facial hair |
1.36 |
3 |
3 |
6.7 |
0.00 |
1.0e+00 |
ATG7 C4orf22 FNDC4 |
Systolic blood pressure, automated reading |
7.23 |
101 |
68 |
151.1 |
0.98 |
3.8e-86 |
AC002558.1 AC003029.1 AC006111.1 AC006547.14 ACP2 ACTRT3 ADRB1 AGT ALDH2 AP3M1 ARHGAP42 ARL14EP ATG7 ATP2B1 C15orf17 C22orf31 C4orf22 CACNB2 CEP68 CERS5 CFDP1 CHP1 CLCN6 CRK CSK CTB-31O20.6 CTSW CWF19L2 DCAF16 DDB2 FAM108C1 FBXO41 FES FIBP GATAD1 GLYR1 GMEB2 GOSR2 GTF2B HECTD4 HELLS HOXA10 HOXC8 IPO11 IRAK1BP1 LFNG LOC338758 LSP1 MADD MAP3K11 MAPKAPK5 MPI MRPS18AP1 MYO9B NAA25 NCOA1 NELFCD NFKBIA NME6 NMT1 NOC3L NR1H3 NRBF2 NSUN6 NT5C2 OLA1 OPRL1 PDIA2 PIGV PLEKHM2 PMS2P5 PTPRJ RGS19 RHOC RNASEH2C RP11-332H18.4 RP4-635E18.7 RP5-1115A15.1 RPP25 SF3B3 SH2B3 SIPA1 SLC26A6 SLC4A7 STAG3L1 SWAP70 TCEA2 TCHP TCTA TH1L TMBIM1 TNFSF12 TRIM59 UBE2Z ULK3 UPF3A USP36 YES1 ZNF318 ZNF831 ZNRF3 |
Angina |
3.30 |
9 |
5 |
11.1 |
0.97 |
7.8e-08 |
FES GNGT2 OPRL1 SLC22A1 SORT1 SPC24 TCEA2 TCF21 ZNF652 |
Medication: Metformin |
2.01 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
FNDC4 TCTA |
Diabetes (father) |
1.65 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
FNDC4 SNF8 |
Pack years adult smoking proportion |
1.40 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
C14orf153 |
Impedance of leg (right) |
2.08 |
43 |
25 |
55.6 |
-0.15 |
3.2e-01 |
AC006547.14 AC091133.1 ARHGAP42 ATG7 C14orf153 CAMK2N2 CEP41 CERS5 CTB-31O20.6 CTD-3032J10.3 CTSW FAM108C1 FES FIBP FNDC4 GCKR GNGT2 GPN1 HELLS HEY2 HMGCR HOXC8 MADD MAP2K5 MYO9B NEGR1 NELFCD NMT1 NOC3L NT5C2 PDXDC2P PMS2P5 RP11-463M16.4 RP11-613D13.5 SENP1 SHISA4 SLC35F6 SNRPC STAG3L1 SWAP70 TH1L ZNF652 ZNF668 |
Leg fat-free mass (left) |
1.97 |
36 |
27 |
60.0 |
-0.09 |
6.1e-01 |
AC006547.14 APOC4 C10orf118 CAMK2N2 CENPW CLIC4 CTD-2349P21.5 DCAF16 EPOR FAM108C1 FIBP FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HEY2 HMGCR MAP2K5 NEGR1 NFKBIA NMT1 NPC1 NRBP1 NT5C2 PDE1A RP11-332H18.4 RP11-613D13.5 SHISA4 SLC35F6 SNRPC STAG3L1 UPF3A USP36 ZNF668 |
Trunk fat percentage |
2.06 |
33 |
14 |
31.1 |
0.65 |
2.8e-05 |
AC091133.1 ACP2 ANKRD13B C14orf153 CHP1 CLOCK CTB-31O20.6 CTSW DBR1 FAM108C1 HMGCR HOXA10 HOXC8 MADD MAP2K5 MYO9B NEGR1 NOC3L NPC1 PDIA2 PDXDC2P RNF34 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 SHISA4 SNRPC STAG3L1 TCTA TNFRSF25 TNFSF12 UPF3A ZNF668 |
Hand grip strength (right) |
1.32 |
8 |
3 |
6.7 |
-0.35 |
3.6e-01 |
C5orf56 CAMK2N2 DCAF16 JARID2 LRPPRC NMT1 PVRL2 RHOC |
Townsend deprivation index at recruitment |
1.11 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MAP2K5 |
Current tobacco smoking |
1.54 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MAPKAPK5 |
Maternal smoking around birth |
1.21 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
C14orf153 C20orf160 |
Fed-up feelings |
1.32 |
6 |
1 |
2.2 |
-0.62 |
1.9e-01 |
AC003029.1 ALDH2 HECTD4 MAPKAPK5 NR1H3 SH2B3 |
Relative age voice broke |
1.33 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP11-613D13.5 |
Taking other prescription medications |
2.15 |
4 |
2 |
4.4 |
0.99 |
8.2e-05 |
ADAM1A HECTD4 SH2B3 ZNF652 |
Age when periods started (menarche) |
1.91 |
14 |
8 |
17.8 |
-0.75 |
7.5e-04 |
CTB-31O20.6 CTSW FIBP LSP1 MADD MAP2K5 NEGR1 NFKBIA NUCB2 PDXDC2P PMS2P5 RP11-613D13.5 SIPA1 STAG3L1 |
Heel bone mineral density (BMD) T-score, automated (left) |
1.64 |
12 |
5 |
11.1 |
0.13 |
6.9e-01 |
C14orf153 CMIP CYB5D1 DDB2 FIBP GATAD1 MAP3K11 RNASEH2C RP5-1115A15.1 SIPA1 TCTA ZNRF3 |
High blood pressure |
10.86 |
172 |
117 |
260.0 |
0.99 |
4.5e-164 |
AC002558.1 AC003029.1 AC006111.1 AC091133.1 ACE ACP2 ACTRT3 ADAM1A ADRB1 AGT AKR1B15 ALDH2 AP3M1 ARHGAP42 ARID3B ATG7 ATP2B1 B3GALT2 C10orf118 C11orf1 C14orf153 C15orf17 C1GALT1 C20orf160 C22orf31 C4orf22 CACNB2 CAMK2N2 CCDC33 CD164L2 CENPW CEP41 CEP68 CERS5 CFDP1 CHDH CHMP1A CHP1 CISD2 CLCN6 CLIC4 CMIP CSK CTB-31O20.6 CTD-3032J10.3 CTSW CWF19L2 CYB5D1 DBR1 DCAF16 DDB2 ENPEP ERAP1 EXOC4 FAM108C1 FBF1 FBXO41 FES FIBP FUT2 GLYR1 GMEB2 GOSR2 GTF2B HECTD4 HELLS HEY2 HIBADH HOXA10 HOXC8 HRCT1 IPO11 IRAK1BP1 JARID2 KB-1107E3.1 LDB3 LFNG LOC338758 LSP1 MADD MAP2K5 MAP3K11 MAPKAPK5 MARCH2 MET MOBP MPI MRPS18AP1 MYO9B NAA25 NADK NCOA1 NDUFAF6 NEGR1 NELFCD NME6 NMT1 NOC3L NR1H3 NRBF2 NSUN6 NT5C2 NUCB2 OLA1 OPRL1 PCCB PCNX PDE1A PDIA2 PDXK PIGV PLCB1 PLEKHM2 PMS2P5 PTPRJ PVRIG RGS19 RHOC RNASEH2C RNF34 RP11-1055B8.4 RP11-332H18.4 RP11-373D23.3 RP11-463M16.4 RP11-538P18.2 RP11-613D13.5 RP11-810M2.2 RP4-635E18.7 RP4-798A10.2 RP5-1115A15.1 RPP25 RYK SAV1 SDCCAG8 SENP1 SF3B3 SH2B3 SIPA1 SLC26A10 SLC26A6 SLC35F6 SLC4A7 SNF8 SNX15 SNX16 STAG3L1 SWAP70 TBC1D19 TCEA2 TCF21 TCHP TH1L THAP9-AS1 THEM6 TNFRSF25 TNFSF12 TNNT3 TPD52L2 TRIM59 TSPY26P UBE2Z ULK3 UPF3A VANGL1 VEGFB YEATS4 ZC3HC1 ZNF318 ZNF652 ZNF668 ZNF831 ZNRF3 |
Hayfever, allergic rhinitis or eczema |
1.97 |
11 |
7 |
15.6 |
0.26 |
3.9e-01 |
ADAM1A C11orf1 C5orf56 CHP1 KRTCAP3 MPI PVRL2 RP11-373D23.3 RP5-1115A15.1 SMARCE1 ZNF652 |
Supplements: Glucosamine |
1.55 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
CSK NRBF2 ULK3 |
Medication: Atenolol |
4.06 |
7 |
3 |
6.7 |
0.96 |
7.8e-04 |
ARHGAP42 CLCN6 FES HECTD4 MET RHOC SH2B3 |
Medication: Levothyroxine sodium |
2.53 |
8 |
7 |
15.6 |
0.99 |
7.8e-08 |
AC003029.1 ADAM1A ALDH2 HECTD4 MAPKAPK5 NAA25 SH2B3 SNRPC |
Sitting height |
1.50 |
41 |
26 |
57.8 |
-0.49 |
5.7e-04 |
ADRB1 ARL14EP C10orf118 C20orf160 CENPW CERS5 CHP1 CLOCK DCAF16 FNDC4 FUT2 GATAD1 GCKR GLYR1 GOSR2 GPN1 GTF2B HELLS HEY2 JARID2 KRTCAP3 MARCH2 NFKBIA NMT1 NRBP1 PPM1G PTPRJ RGS12 RP11-463M16.4 RP11-538P18.2 SLC35F6 SLC4A7 SNF8 SNRPC TMBIM1 UBE2Z UPF3A YEATS4 ZNF652 ZNF831 ZNRF3 |
High blood pressure (mother) |
4.30 |
16 |
3 |
6.7 |
0.96 |
8.3e-10 |
AGT ARHGAP42 CENPW CLCN6 FES HOXA10 HOXC8 LSP1 NT5C2 NUCB2 PIGV SENP1 SLC4A7 TNFRSF25 UBE2Z ZNF831 |
Body mass index (BMI) |
2.34 |
36 |
26 |
57.8 |
0.76 |
2.2e-08 |
AC006547.14 AC091133.1 ACP2 ANKRD13B C14orf153 CEP41 CTB-31O20.6 CTSW DCAF16 FAM108C1 FIBP FNDC4 HEY2 HMGCR MADD MAP2K5 NEGR1 NPC1 NT5C2 OLA1 PCCB PDIA2 PDXDC2P PMS2P5 RP11-613D13.5 RP5-1115A15.1 RPP25 SF3B3 SHISA4 SIPA1 SNF8 SNRPC STAG3L1 TCTA TXNL4B ZNF668 |
Impedance of leg (left) |
2.03 |
41 |
25 |
55.6 |
-0.15 |
3.3e-01 |
AC006547.14 AC091133.1 ARHGAP42 ATG7 C14orf153 CAMK2N2 CEP41 CERS5 CTB-31O20.6 CTD-3032J10.3 CTSW FAM108C1 FES FNDC4 GCKR GNGT2 GPN1 HELLS HEY2 HMGCR HOXC8 MADD MAP2K5 MYO9B NEGR1 NELFCD NFKBIA NMT1 NOC3L NT5C2 PDXDC2P PMS2P5 RP11-463M16.4 RP11-613D13.5 SHISA4 SLC35F6 SNRPC STAG3L1 SWAP70 ZNF652 ZNF668 |
Leg predicted mass (left) |
1.96 |
36 |
26 |
57.8 |
-0.09 |
6.1e-01 |
AC006547.14 APOC4 C10orf118 CAMK2N2 CENPW CLIC4 CTD-2349P21.5 DCAF16 EPOR FAM108C1 FIBP FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HEY2 HMGCR MAP2K5 NEGR1 NFKBIA NMT1 NPC1 NRBP1 NT5C2 PDE1A RP11-332H18.4 RP11-613D13.5 SHISA4 SLC35F6 SNRPC STAG3L1 UPF3A USP36 ZNF668 |
Trunk fat mass |
2.01 |
35 |
17 |
37.8 |
0.61 |
7.2e-05 |
ACP2 ANKRD13B CLOCK CTB-31O20.6 CTSW DBR1 ERAP1 FAM108C1 FIBP HEY2 HMGCR HOXA10 KB-1107E3.1 MADD MAP2K5 NEGR1 NPC1 NT5C2 OLA1 PDIA2 PDXDC2P PTPRJ RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SHISA4 SNRPC STAG3L1 TCTA TNFRSF25 TXNL4B UPF3A USP36 ZNF668 |
Waist circumference |
2.34 |
31 |
20 |
44.4 |
0.80 |
5.2e-08 |
AC006547.14 ANKRD13B C14orf153 CMIP CTB-31O20.6 CTSW FAM108C1 FIBP HEY2 HMGCR HOXC8 KB-1107E3.1 MAP2K5 NEGR1 NPC1 OLA1 PCCB PDIA2 PDXDC2P PMS2P5 RP11-613D13.5 RP11-810M2.2 RPP25 SHISA4 SIPA1 SNRPC STAG3L1 TCTA TNFRSF25 USP36 ZNF668 |
Number of incorrect matches in round |
1.17 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ZNF668 |
Past tobacco smoking |
1.56 |
5 |
1 |
2.2 |
-0.64 |
2.4e-01 |
AC003029.1 ADAM1A MAP2K5 NPC1 SH2B3 |
Alcohol usually taken with meals |
1.32 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NEGR1 |
Nervous feelings |
1.15 |
4 |
0 |
0.0 |
-0.28 |
7.2e-01 |
NR1H3 NT5C2 PCCB ZNF668 |
Frequency of tenseness / restlessness in last 2 weeks |
1.06 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NT5C2 |
Hearing difficulty/problems with background noise |
1.60 |
5 |
1 |
2.2 |
-0.73 |
1.6e-01 |
C14orf153 CSK MPI ULK3 ZNF318 |
Hair/balding pattern: Pattern 2 |
1.38 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
C4orf22 CPEB2 |
Had menopause |
1.54 |
5 |
3 |
6.7 |
-0.61 |
2.7e-01 |
CHP1 KRTCAP3 NRBP1 PPM1G RNASEH2C |
Forced vital capacity (FVC) |
1.44 |
15 |
9 |
20.0 |
-0.55 |
3.2e-02 |
ACP2 ANKRD13B CENPW DCAF16 DDB2 GMEB2 MAP3K11 NCOA1 RGS12 RHOC RP11-538P18.2 TMBIM1 UBE2Z UPF3A ZNF668 |
Heel bone mineral density (BMD) T-score, automated (right) |
1.67 |
12 |
6 |
13.3 |
-0.02 |
9.5e-01 |
ACP2 C14orf153 CYB5D1 DDB2 FIBP GATAD1 MAP3K11 RNASEH2C RP5-1115A15.1 SIPA1 TCTA ZNRF3 |
Qualifications: None of the above |
1.32 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
IRAK1BP1 NEGR1 UBE2Z |
Mouth/teeth dental problems |
1.49 |
4 |
0 |
0.0 |
-0.99 |
8.8e-03 |
C14orf153 FUT2 NPEPPS SIPA1 |
Heart attack |
2.88 |
9 |
2 |
4.4 |
0.95 |
5.0e-06 |
ANKRD13B FES PCCB SLC22A1 SORT1 SPC24 TCF21 ZC3HC1 ZNF652 |
Allergy |
1.84 |
9 |
6 |
13.3 |
-0.53 |
9.3e-02 |
C11orf1 C5orf56 CHP1 GMEB2 RP11-373D23.3 RP5-1115A15.1 SMARCE1 TMBIM1 ZNF652 |
Diabetes (self-reported) |
2.19 |
5 |
3 |
6.7 |
-0.20 |
7.5e-01 |
FNDC4 NRBP1 PMS2P5 PPM1G TCTA |
Medication: Ramipril |
4.02 |
4 |
2 |
4.4 |
0.99 |
6.0e-03 |
ADAM1A ARHGAP42 CMIP CSK |
Medication: Simvastatin |
6.09 |
30 |
19 |
42.2 |
0.95 |
2.4e-16 |
APOB BCAM C19orf52 CTD-2349P21.5 DOCK7 EPOR FES FNDC4 FUT2 GPN1 HMGCR LOC100272146 LPL LRPPRC NPC1L1 OPRL1 PAFAH1B2 PIGV PVRL2 RNASEH2C SIPA1 SORT1 SPC24 TCEA2 TOMM40 TXNL4B VEGFB YEATS4 ZNF259 ZNF831 |
Fluid intelligence score |
1.44 |
4 |
3 |
6.7 |
-0.57 |
4.3e-01 |
ACP2 DCAF16 FBXO41 NEGR1 |
Illnesses of siblings |
3.51 |
7 |
2 |
4.4 |
-0.97 |
4.3e-04 |
ANKRD13B FES HECTD4 MRPS18AP1 PDIA2 SH2B3 ZNF668 |
Neuroticism score |
1.12 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
NR1H3 |
Weight |
2.07 |
45 |
25 |
55.6 |
0.29 |
4.3e-02 |
AC006547.14 APOC4 C10orf118 CTB-31O20.6 CTD-2349P21.5 CTSW DCAF16 EPOR ERAP1 FAM108C1 FIBP FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HEY2 HMGCR KB-1107E3.1 MADD MAP2K5 MET NEGR1 NFKBIA NPC1 NT5C2 OLA1 PDIA2 PDXDC2P PMS2P5 PTPRJ RP11-332H18.4 RP11-613D13.5 RP11-810M2.2 RPP25 SF3B3 SHISA4 SNRPC STAG3L1 TCTA TXNL4B UPF3A USP36 ZNF668 |
Impedance of arm (right) |
2.17 |
44 |
25 |
55.6 |
-0.28 |
4.8e-02 |
AC006547.14 ACTR1B BZRAP1-AS1 C22orf31 CCDC33 CERS5 CISD2 CMIP CTB-31O20.6 CTD-3032J10.3 CTSW EIF2A FIBP FNDC4 GCKR GNGT2 GPN1 HELLS HEY2 HMGCR HOXA10 HOXC8 LSP1 MARCH2 MYO9B NEGR1 NOC3L NRBF2 PCCB PDE1A PMS2P5 RP11-373D23.3 RP11-463M16.4 RYK SENP1 SHISA4 SLC4A7 SNRPC SNX16 STAG3L1 TNFSF12 TSPY26P ZNF652 ZNF668 |
Arm fat percentage (right) |
2.19 |
35 |
20 |
44.4 |
0.76 |
5.2e-08 |
AC091133.1 ACP2 ANKRD13B C14orf153 CHP1 CPEB2 CTB-31O20.6 CTSW DCAF16 DYNC2LI1 ERAP1 FAM108C1 FBF1 HMGCR HOXA10 HOXC8 MADD MAP2K5 NEGR1 NPC1 OLA1 PDIA2 PDXDC2P PMS2P5 RP11-613D13.5 RP5-1115A15.1 SHISA4 SIPA1 SNF8 SNRPC STAG3L1 TCTA TNFRSF25 TXNL4B ZNF668 |
Trunk fat-free mass |
2.19 |
46 |
32 |
71.1 |
-0.38 |
7.4e-03 |
AC003029.1 ALDH2 APOC4 C10orf118 CAMK2N2 CENPW CTD-2349P21.5 CTD-3032J10.3 DCAF16 EPOR FIBP FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HELLS HEY2 HMGCR KRTCAP3 MARCH2 MET MYO9B NCOA1 NFKBIA NMT1 NPC1 NRBP1 NT5C2 PDE1A PPM1G RP11-332H18.4 RP11-373D23.3 RP11-613D13.5 SH2B3 SHISA4 SLC35F6 SLC4A7 SNRPC SORT1 TMBIM1 UBE2Z UPF3A USP36 ZNF668 |
Hip circumference |
2.14 |
37 |
18 |
40.0 |
0.18 |
2.7e-01 |
AC003029.1 ACP2 CLCN6 CLOCK CTB-31O20.6 FAM108C1 FBF1 FNDC4 GCKR GPN1 HECTD4 HEY2 HMGCR KB-1107E3.1 MADD MAP2K5 MAPKAPK5 NEGR1 NFKBIA NPC1 NPPA NT5C2 OLA1 PDIA2 PDXDC2P PMS2P5 RP11-613D13.5 SF3B3 SH2B3 SHISA4 SNRPC STAG3L1 TXNL4B UPF3A USP36 VEGFB ZNF668 |
Alcohol intake versus 10 years previously |
1.73 |
5 |
1 |
2.2 |
0.54 |
3.5e-01 |
FNDC4 FUT2 GCKR HIBADH NEGR1 |
Father's age at death |
2.35 |
5 |
2 |
4.4 |
-0.98 |
3.2e-03 |
C15orf17 FES MPI SH2B3 SORT1 |
Worrier / anxious feelings |
1.26 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
CPEB2 NT5C2 |
Frequency of tiredness / lethargy in last 2 weeks |
1.68 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
MAPKAPK5 SNF8 UBE2Z |
Hair/balding pattern: Pattern 3 |
1.34 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
C4orf22 |
Forced expiratory volume in 1-second (FEV1) |
1.34 |
14 |
3 |
6.7 |
-0.53 |
4.9e-02 |
ARHGAP42 C1GALT1 DCAF16 EPOR HSPA4 NCOA1 NFKBIA NRBF2 RGS12 RHOC RP11-538P18.2 TMBIM1 UPF3A ZNF668 |
Pulse rate |
1.43 |
5 |
3 |
6.7 |
0.58 |
3.1e-01 |
FNDC4 GCKR MET TCF21 TCTA |
Qualifications: A levels/AS levels or equivalent |
1.28 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
FBXO41 NEGR1 STAG3L1 |
Mouth/teeth dental problems: Dentures |
1.33 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
C5orf56 FUT2 |
Asthma |
1.56 |
5 |
3 |
6.7 |
0.45 |
3.1e-01 |
C11orf1 C19orf52 C5orf56 RP5-1115A15.1 ZNF652 |
Medication: Cholesterol lowering |
6.63 |
34 |
22 |
48.9 |
0.92 |
6.7e-16 |
ABHD1 APOB ARHGAP42 BCAM C19orf52 CHP1 DOCK7 EPOR FES FNDC4 FUT2 GCKR GPN1 HMGCR LPL LRPPRC NPEPPS NRBP1 OPRL1 PAFAH1B2 PCCB PVRIG PVRL2 RNASEH2C SIPA1 SLC22A1 SORT1 SPC24 TCEA2 TNFRSF25 TOMM40 TXNL4B ZNF259 ZNF831 |
Depression (self-reported) |
0.95 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP5-1115A15.1 |
Illnesses of mother |
3.20 |
3 |
1 |
2.2 |
-0.98 |
2.4e-02 |
FES SNF8 UBE2Z |
Forced expiratory volume in 1-second (FEV1), Best measure |
1.36 |
11 |
4 |
8.9 |
-0.73 |
1.2e-02 |
ACP2 C1GALT1 DCAF16 EPOR HSPA4 NFKBIA NRBF2 RGS12 RP11-538P18.2 UPF3A ZNF668 |
Pulse wave Arterial Stiffness index |
1.49 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ADAM1A VEGFB |
Impedance of arm (left) |
2.18 |
41 |
24 |
53.3 |
-0.21 |
1.5e-01 |
AC006547.14 ACTR1B C22orf31 CCDC33 CERS5 CISD2 CMIP CTD-3032J10.3 CTSW EIF2A FAM108C1 FIBP FNDC4 GCKR GNGT2 GPN1 HECTD4 HELLS HEY2 HMGCR HOXC8 LSP1 MARCH2 MYO9B NEGR1 NOC3L NRBF2 PCCB PDE1A RP11-373D23.3 RP11-463M16.4 RP11-613D13.5 RYK SH2B3 SHISA4 SLC4A7 SNRPC STAG3L1 TNFSF12 ZNF652 ZNF668 |
Arm fat mass (right) |
2.18 |
36 |
19 |
42.2 |
0.71 |
4.4e-07 |
AC091133.1 ACP2 ANKRD13B C14orf153 CTB-31O20.6 CTSW ERAP1 FAM108C1 FIBP FNDC4 HEY2 HMGCR HOXA10 MADD MAP2K5 NEGR1 NPC1 NT5C2 OLA1 PDIA2 PDXDC2P PMS2P5 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SF3B3 SHISA4 SIPA1 SNRPC STAG3L1 TCTA TNFRSF25 TXNL4B USP36 ZNF668 |
Trunk predicted mass |
2.20 |
48 |
31 |
68.9 |
-0.37 |
7.5e-03 |
AC003029.1 ALDH2 APOC4 C10orf118 CAMK2N2 CENPW CTD-2349P21.5 CTD-3032J10.3 DCAF16 EPOR FIBP FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HELLS HEY2 HMGCR JARID2 KRTCAP3 MARCH2 MET MYO9B NCOA1 NEGR1 NFKBIA NMT1 NPC1 NRBP1 NT5C2 PDE1A PPM1G RP11-332H18.4 RP11-373D23.3 RP11-613D13.5 SH2B3 SHISA4 SLC35F6 SLC4A7 SNRPC SORT1 TMBIM1 UBE2Z UPF3A USP36 ZNF668 |
Standing height |
1.82 |
67 |
48 |
106.7 |
-0.53 |
1.8e-06 |
AC091133.1 ACP2 ADRB1 APOC4 ARL14EP C10orf118 C14orf153 C19orf52 C5orf56 CENPW CERS5 CFDP1 CHP1 CLIC4 CLOCK CTD-2349P21.5 DCAF16 DDB2 DYNC2LI1 EPOR FNDC4 FUT2 GATAD1 GCKR GLYR1 GPN1 GTF2B HECTD4 HEY2 KRTCAP3 LOC100272146 MAP3K11 MARCH2 NCOA1 NFKBIA NMT1 NPC1 NPEPPS NRBP1 PDE1A PDXDC2P PIGV PPM1G PTPRJ RGS12 RHOC RP11-1055B8.4 RP11-332H18.4 RP11-463M16.4 RP11-538P18.2 RP4-635E18.7 RP5-1115A15.1 RYK SH2B3 SLC4A7 SNF8 SNRPC SORT1 SPC24 TMBIM1 UBE2Z UPF3A USP36 YEATS4 ZNF318 ZNF652 ZNF831 |
Tense / 'highly strung' |
1.07 |
4 |
1 |
2.2 |
-0.03 |
9.7e-01 |
NT5C2 RP5-1115A15.1 THAP9-AS1 ZNF668 |
Seen doctor (GP) for nerves, anxiety, tension or depression |
1.15 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CAMK2N2 NEGR1 |
Hair/balding pattern: Pattern 4 |
1.35 |
5 |
2 |
4.4 |
0.53 |
3.5e-01 |
C4orf22 CENPW CERS5 CLIC4 RP5-1115A15.1 |
Birth weight of first child |
2.48 |
12 |
4 |
8.9 |
-0.98 |
1.5e-11 |
AC003029.1 ALDH2 CLCN6 CSK DCAF16 FES GNGT2 GTF2B HECTD4 OPRL1 RPP25 SH2B3 |
Peak expiratory flow (PEF) |
1.36 |
5 |
2 |
4.4 |
-0.68 |
2.1e-01 |
C1GALT1 DCAF16 FUT2 TCF21 ZFP36L2 |
Medication: Paracetamol |
1.41 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
SDCCAG8 |
Headache pain in last month |
1.46 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
SDCCAG8 |
Medication for cholesterol, blood pressure or diabetes |
7.34 |
47 |
18 |
40.0 |
-0.98 |
1.2e-37 |
AC002558.1 ACE APOB ARHGAP42 ATP2B1 C11orf1 C4orf22 CHP1 CLCN6 CSK CTD-2349P21.5 CTD-3032J10.3 CTSW EPOR FAM108C1 FES FUT2 HMGCR JARID2 LFNG LOC338758 LRPPRC NME6 OPRL1 PAFAH1B2 PDXK PLCB1 PVRIG RHOC SENP1 SERTAD4 SH2B3 SIPA1 SLC22A1 SLC4A7 SORT1 SPC24 TCEA2 TCF21 TCTA TH1L TSPY26P ULK3 UPF3A ZNF259 ZNF652 ZNF831 |
Gout (self-reported) |
2.79 |
10 |
7 |
15.6 |
0.93 |
2.5e-05 |
ABHD1 FNDC4 GCKR GPN1 KRTCAP3 MAP3K11 NRBP1 PPM1G SH2B3 SIPA1 |
Hypothyroidism/myxoedema (self-reported) |
2.39 |
7 |
7 |
15.6 |
0.99 |
2.7e-06 |
AC003029.1 ADAM1A ALDH2 HECTD4 MAPKAPK5 NAA25 SH2B3 |
Medication: Amlodipine |
4.70 |
17 |
10 |
22.2 |
0.95 |
1.0e-09 |
ARHGAP42 CD164L2 CLCN6 FAM108C1 FES GLYR1 LSP1 RHOC RNF34 RP4-635E18.7 SENP1 SIPA1 SLC35F6 SLC4A7 TNFSF12 TNNT3 ZNF318 |
Medication: Ventolin 100micrograms inhaler |
1.26 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZNF652 |
Birth weight |
2.11 |
15 |
8 |
17.8 |
-0.80 |
3.6e-04 |
AC003029.1 ADAM1A ADRB1 ALDH2 C11orf1 CFDP1 CTD-2349P21.5 DCAF16 FES FUT2 HECTD4 SH2B3 THADA TNNT3 ZNRF3 |
High blood pressure (siblings) |
4.17 |
11 |
4 |
8.9 |
0.97 |
2.3e-07 |
ACP2 ARHGAP42 CLCN6 FES HECTD4 NR1H3 NRBF2 PDIA2 SH2B3 SLC4A7 ZNF668 |
Forced vital capacity (FVC), Best measure |
1.42 |
15 |
7 |
15.6 |
-0.71 |
1.4e-03 |
ACP2 CENPW DCAF16 DDB2 EPOR GMEB2 MADD NCOA1 RGS12 RHOC RP11-538P18.2 TMBIM1 UBE2Z UPF3A ZNF668 |
Body fat percentage |
2.19 |
36 |
19 |
42.2 |
0.70 |
9.0e-07 |
AC091133.1 ACP2 ANKRD13B C14orf153 CHP1 CRK CTB-31O20.6 CTSW DCAF16 ERAP1 FAM108C1 HELLS HMGCR HOXA10 HOXC8 MADD MAP2K5 NEGR1 NOC3L NPC1 OLA1 PDIA2 PDXDC2P PVRL2 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SHISA4 SNF8 SNRPC STAG3L1 TCTA TNFRSF25 TXNL4B ZNF668 |
Leg fat percentage (right) |
2.23 |
32 |
21 |
46.7 |
0.85 |
6.3e-10 |
ACP2 ANKRD13B CHP1 CRK CTB-31O20.6 CTSW DCAF16 DYNC2LI1 ERAP1 FAM108C1 GTF2B HELLS HMGCR MADD MAP2K5 MOBP NEGR1 NMT1 NPC1 OLA1 PDIA2 PDXDC2P RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SHISA4 SNRPC STAG3L1 TCTA TNFRSF25 ZNF668 |
Arm fat-free mass (right) |
2.25 |
44 |
28 |
62.2 |
-0.19 |
2.2e-01 |
AC006547.14 APOC4 C10orf118 CENPW CTD-2349P21.5 CTSW DCAF16 EPOR FAM108C1 FIBP FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HEY2 HMGCR KRTCAP3 MAP2K5 MARCH2 MET MYO9B NEGR1 NFKBIA NMT1 NPC1 NRBP1 PDE1A PPM1G RP11-332H18.4 RP11-373D23.3 RP11-613D13.5 SH2B3 SHISA4 SLC35F6 SNRPC SORT1 TCTA TMBIM1 UBE2Z UPF3A USP36 ZNF668 |
Comparative body size at age 10 |
2.12 |
14 |
8 |
17.8 |
0.32 |
2.1e-01 |
ACP2 ATG7 CERS5 FUT2 MADD MAP2K5 NEGR1 NME6 NPC1 SIPA1 SLC26A6 SNRPC ZNF652 ZNF668 |
Worry too long after embarrassment |
1.15 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
PCCB RGS12 |
Wheeze or whistling in the chest in last year |
1.47 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
C11orf1 ZNF652 |
Pulse wave peak to peak time |
1.45 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ADAM1A |
Shortness of breath walking on level ground |
1.13 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
USP36 |
Qualifications: College or University degree |
1.39 |
12 |
4 |
8.9 |
-0.72 |
5.7e-03 |
CPEB2 DCAF16 FBXO41 GTF2B MET NEGR1 NPC1 RGS12 SDCCAG8 SHISA4 STAG3L1 TNFRSF25 |
Medication for pain relief, constipation, heartburn |
1.87 |
4 |
1 |
2.2 |
-1.00 |
2.9e-03 |
C20orf160 FAM108C1 NPEPPS SDCCAG8 |
Medication: Blood pressure |
7.71 |
61 |
29 |
64.4 |
0.99 |
3.9e-56 |
AC003029.1 AC091133.1 ACE ACP2 ADAM1A ADRB1 ALDH2 ARHGAP42 ATP2B1 C15orf17 C20orf160 C4orf22 CEP41 CHMP1A CISD2 CLCN6 CMIP CSK CTSW CWF19L2 CYB5D1 DCAF16 DDB2 FAM108C1 FBXO41 FES HECTD4 HOXA10 JARID2 LFNG LOC338758 LSP1 MADD MOBP MRPL35 MRPS18AP1 NME6 NOC3L NR1H3 PDXK PLCB1 PTPRJ PVRIG RHOC RNF34 RP11-463M16.4 RP11-810M2.2 RP4-635E18.7 SENP1 SH2B3 SLC26A6 SLC4A7 TCF21 TH1L TNNT3 TSPY26P ULK3 UPF3A ZNF318 ZNF652 ZNF831 |
Angina (self-reported) |
3.24 |
9 |
4 |
8.9 |
0.97 |
8.6e-08 |
FES GNGT2 OPRL1 SLC22A1 SORT1 SPC24 TCEA2 TCF21 ZNF652 |
Medication: Allopurinol |
2.68 |
7 |
5 |
11.1 |
0.98 |
2.8e-05 |
CYB5D1 FNDC4 GCKR GPN1 KRTCAP3 NRBP1 PPM1G |
Medication: Omeprazole |
1.27 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SNRPC |
Medication: Seretide 50 evohaler |
1.19 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZNF652 |
Mean time to correctly identify matches |
1.63 |
9 |
5 |
11.1 |
0.87 |
1.1e-03 |
AC003029.1 ALDH2 HECTD4 MAPKAPK5 NAA25 OLA1 RP11-810M2.2 SH2B3 TCTA |
Heart disease (mother) |
2.21 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
SLC22A1 |
Whole body fat mass |
2.10 |
37 |
20 |
44.4 |
0.72 |
1.8e-07 |
AC091133.1 ACP2 ANKRD13B C14orf153 CTB-31O20.6 CTSW ERAP1 FAM108C1 FIBP HEY2 HMGCR HOXA10 KB-1107E3.1 MADD MAP2K5 NEGR1 NPC1 NT5C2 OLA1 PDIA2 PDXDC2P PMS2P5 PTPRJ RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SF3B3 SHISA4 SNRPC STAG3L1 TCTA TNFRSF25 TXNL4B UPF3A USP36 ZNF668 |
Leg fat mass (right) |
2.21 |
35 |
19 |
42.2 |
0.84 |
4.8e-11 |
AC091133.1 ANKRD13B C14orf153 CTB-31O20.6 CTSW ERAP1 FAM108C1 FIBP HEY2 HMGCR KB-1107E3.1 MADD MAP2K5 MET MOBP NEGR1 NPC1 OLA1 PDIA2 PDXDC2P PMS2P5 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SF3B3 SHISA4 SNRPC STAG3L1 TCTA TNFRSF25 TSPY26P TXNL4B USP36 ZNF668 |
Arm predicted mass (right) |
2.22 |
42 |
28 |
62.2 |
-0.13 |
4.0e-01 |
AC006547.14 APOC4 C10orf118 CENPW CMIP CTD-2349P21.5 DCAF16 EPOR FAM108C1 FIBP FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HEY2 HMGCR MAP2K5 MARCH2 MET NEGR1 NFKBIA NMT1 NPC1 NRBP1 PDE1A PPM1G RP11-332H18.4 RP11-373D23.3 RP11-613D13.5 SH2B3 SHISA4 SLC35F6 SNRPC SORT1 STAG3L1 TCTA TMBIM1 UBE2Z USP36 ZNF668 |
Pulse rate, automated reading |
1.97 |
17 |
10 |
22.2 |
0.46 |
5.6e-02 |
ABHD1 ACP2 C11orf1 C14orf153 FNDC4 GCKR GPN1 KRTCAP3 MET NEGR1 NR1H3 NRBP1 PPM1G PVRIG SNRPC TCF21 TCTA |
Alcohol intake frequency. |
2.53 |
15 |
13 |
28.9 |
0.72 |
1.7e-03 |
ABHD1 FNDC4 FUT2 GCKR GPN1 KRTCAP3 LRPPRC NPC1 NRBP1 PDXDC2P PMS2P5 PPM1G RGS12 TCTA ZNF668 |
Comparative height size at age 10 |
1.78 |
41 |
23 |
51.1 |
-0.51 |
5.2e-04 |
AC003029.1 ALDH2 APOC4 C14orf153 C5orf56 CENPW CTD-2349P21.5 DCAF16 DDB2 FAM108C1 FNDC4 FUT2 GATAD1 GCKR GLYR1 GPN1 GTF2B HECTD4 HEY2 MAPKAPK5 NCOA1 NFKBIA NPC1 NRBP1 NUCB2 PIGV PTPRJ RGS12 RP11-332H18.4 RP11-613D13.5 RP11-810M2.2 RP4-635E18.7 RYK SH2B3 SORT1 SPC24 TMBIM1 UBE2Z UPF3A USP36 ZFP36L2 |
Number of full sisters |
1.29 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NRBF2 |
Overall health rating |
2.46 |
12 |
4 |
8.9 |
0.99 |
1.2e-12 |
AC091133.1 C14orf153 CEP68 CTSW NPC1 PDIA2 PMS2P5 SIPA1 SNRPC TSPY26P ZNF652 ZNF668 |
Chest pain or discomfort |
1.60 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
USP36 |
Had major operations |
1.18 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZNF652 |
Qualifications: NVQ or HND or HNC or equivalent |
1.53 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
AC003029.1 |
Medication: Aspirin |
3.70 |
7 |
2 |
4.4 |
0.97 |
2.9e-04 |
AC091133.1 FES OPRL1 RP11-463M16.4 SERTAD4 SLC22A1 SORT1 |
Knee pain experienced in last month |
1.58 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZNF668 |
Hypertension (Self-reported) |
10.81 |
173 |
117 |
260.0 |
0.99 |
1.7e-166 |
AC002558.1 AC003029.1 AC006111.1 AC091133.1 ACE ACP2 ACTRT3 ADAM1A ADRB1 AGT AKR1B15 ALDH2 AP3M1 ARHGAP42 ARID3B ATG7 ATP2B1 C10orf118 C11orf1 C14orf153 C15orf17 C1GALT1 C20orf160 C22orf31 C4orf22 CACNB2 CAMK2N2 CCDC33 CD164L2 CENPW CEP41 CEP68 CERS5 CFDP1 CHDH CHMP1A CHP1 CISD2 CLCN6 CLIC4 CMIP CSK CTB-31O20.6 CTD-3032J10.3 CTSW CWF19L2 CYB5D1 DBR1 DCAF16 DDB2 ENPEP ERAP1 EXOC4 FAM108C1 FBF1 FBXO41 FES FIBP FUT2 GLYR1 GMEB2 GOSR2 GTF2B HECTD4 HELLS HEY2 HIBADH HOXA10 HOXC8 HRCT1 IPO11 IRAK1BP1 JARID2 KB-1107E3.1 LDB3 LFNG LOC338758 LSP1 MADD MAP2K5 MAP3K11 MAPKAPK5 MARCH2 MECR MET MOBP MPI MRPS18AP1 MYO9B NAA25 NADK NCOA1 NDUFAF6 NEGR1 NELFCD NME6 NMT1 NOC3L NR1H3 NRBF2 NSUN6 NT5C2 NUCB2 OLA1 OPRL1 PCCB PCNX PDE1A PDIA2 PDXK PIGV PLCB1 PLEKHM2 PMS2P5 PTPRJ PVRIG RGS19 RHOC RNASEH2C RNF34 RP11-1055B8.4 RP11-332H18.4 RP11-373D23.3 RP11-463M16.4 RP11-538P18.2 RP11-613D13.5 RP11-810M2.2 RP4-635E18.7 RP5-1115A15.1 RPP25 RYK SAV1 SDCCAG8 SENP1 SF3B3 SH2B3 SIPA1 SLC22A1 SLC26A10 SLC26A6 SLC35F6 SLC4A7 SMARCE1 SNF8 SNX15 SNX16 STAG3L1 SWAP70 TBC1D19 TCEA2 TCF21 TCHP TH1L THAP9-AS1 THEM6 TNFRSF25 TNFSF12 TNNT3 TPD52L2 TRIM59 TSPY26P UBE2Z ULK3 UPF3A VANGL1 VEGFB YEATS4 ZC3HC1 ZNF318 ZNF652 ZNF668 ZNF831 ZNRF3 |
Illnesses of father: Heart disease |
2.72 |
8 |
3 |
6.7 |
0.97 |
1.3e-05 |
DYNC2LI1 EPOR FES LPL NPC1L1 SLC22A1 SORT1 TCF21 |
Smoking status: Previous |
1.59 |
5 |
0 |
0.0 |
0.66 |
2.3e-01 |
AC003029.1 HECTD4 MAP2K5 NPC1 SH2B3 |
Forced expiratory volume in 1-second (FEV1), predicted |
1.36 |
4 |
1 |
2.2 |
-0.94 |
6.2e-02 |
CTD-2349P21.5 DCAF16 RP11-332H18.4 UBE2Z |
Whole body fat-free mass |
2.14 |
45 |
34 |
75.6 |
-0.24 |
1.1e-01 |
AC006547.14 APOC4 C10orf118 CAMK2N2 CENPW CTD-2349P21.5 DCAF16 EPOR FAM108C1 FIBP FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HELLS HEY2 HMGCR MARCH2 MET MYO9B NEGR1 NFKBIA NMT1 NPC1 NRBP1 NT5C2 PDE1A PPM1G RP11-332H18.4 RP11-373D23.3 RP11-613D13.5 SH2B3 SHISA4 SLC35F6 SLC4A7 SNRPC SORT1 STAG3L1 TMBIM1 UBE2Z UPF3A USP36 ZNF668 |
Leg fat-free mass (right) |
1.97 |
37 |
27 |
60.0 |
-0.13 |
4.5e-01 |
AC006547.14 APOC4 C10orf118 CAMK2N2 CENPW CLIC4 CTD-2349P21.5 DCAF16 FAM108C1 FIBP FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HELLS HEY2 HMGCR MAP2K5 MYO9B NEGR1 NFKBIA NMT1 NPC1 NRBP1 NT5C2 PDE1A RP11-332H18.4 RP11-613D13.5 SHISA4 SLC35F6 SNRPC STAG3L1 UPF3A USP36 ZNF668 |
Arm fat percentage (left) |
2.21 |
34 |
23 |
51.1 |
0.76 |
7.4e-08 |
AC091133.1 ACP2 ANKRD13B C14orf153 CHP1 CTB-31O20.6 CTSW DCAF16 DYNC2LI1 FAM108C1 FBF1 HMGCR HOXA10 HOXC8 MADD MAP2K5 NEGR1 NPC1 OLA1 PDIA2 PDXDC2P PMS2P5 RNF34 RP11-613D13.5 RP5-1115A15.1 SHISA4 SIPA1 SNF8 SNRPC STAG3L1 TCTA TNFRSF25 TXNL4B ZNF668 |
Average weekly red wine intake |
1.51 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
C15orf17 NPC1 ULK3 |
Mood swings |
1.28 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ACP2 NR1H3 |
Loneliness, isolation |
1.30 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PTPRJ |
Long-standing illness, disability or infirmity |
1.94 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
CHP1 NEGR1 ZNF652 |
Diabetes diagnosed by doctor |
2.47 |
9 |
3 |
6.7 |
0.11 |
7.9e-01 |
CTSW DBR1 FNDC4 GPN1 NRBP1 PMS2P5 PPM1G SLC22A1 TCTA |
Friendships satisfaction |
1.03 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NPC1 |
Qualifications: nursing, teaching |
1.21 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
NEGR1 |
Mouth/teeth dental problems: Mouth ulcers |
1.20 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
TRIM59 |
Medication for cholesterol |
5.84 |
21 |
7 |
15.6 |
-0.97 |
2.1e-13 |
ACE ARHGAP42 ATG7 C4orf22 CENPW DOCK7 FNDC4 FUT2 GCKR HOXA10 HOXC8 JARID2 LSP1 PIGV PLCB1 RHOC SENP1 SH2B3 SORT1 ZNF668 ZNF831 |
Mineral and other dietary supplements |
1.31 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NRBF2 |
Breast cancer (self-reported) |
1.19 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
SLC4A7 |
Asthma (self-reported) |
1.53 |
4 |
3 |
6.7 |
0.72 |
1.0e-01 |
C5orf56 FBF1 RP5-1115A15.1 ZNF652 |
Osteoarthritis (self-reported) |
1.42 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RPP25 |
Medication: Aspirin |
3.71 |
5 |
2 |
4.4 |
0.96 |
1.9e-03 |
FES RP11-463M16.4 SLC22A1 SORT1 VEGFB |
Illnesses of father: None of the above (group 1) |
2.75 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
DYNC2LI1 FES |
Smoking status: Current |
1.56 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MAPKAPK5 |
Forced expiratory volume in 1-second (FEV1), predicted percentage |
1.14 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
NRBF2 RP11-538P18.2 ZNF668 |
Whole body water mass |
2.15 |
45 |
33 |
73.3 |
-0.24 |
1.1e-01 |
AC006547.14 APOC4 C10orf118 CAMK2N2 CENPW CTD-2349P21.5 DCAF16 EPOR FAM108C1 FIBP FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HELLS HEY2 HMGCR MAP2K5 MARCH2 MET MYO9B NEGR1 NFKBIA NMT1 NPC1 NRBP1 NT5C2 PDE1A PPM1G RP11-332H18.4 RP11-373D23.3 RP11-613D13.5 SH2B3 SHISA4 SLC35F6 SNRPC SORT1 STAG3L1 TMBIM1 UBE2Z UPF3A USP36 ZNF668 |
Leg predicted mass (right) |
1.96 |
38 |
25 |
55.6 |
-0.10 |
5.3e-01 |
AC006547.14 APOC4 C10orf118 CAMK2N2 CENPW CLIC4 CTD-2349P21.5 DCAF16 FAM108C1 FIBP FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HELLS HEY2 HMGCR MAP2K5 MYO9B NEGR1 NFKBIA NMT1 NPC1 NRBP1 NT5C2 PDE1A PTPRJ RP11-332H18.4 RP11-613D13.5 SHISA4 SLC35F6 SNRPC STAG3L1 UPF3A USP36 ZNF668 |
Arm fat mass (left) |
2.13 |
35 |
18 |
40.0 |
0.70 |
1.7e-06 |
AC091133.1 ACP2 ANKRD13B C14orf153 CTB-31O20.6 CTSW ERAP1 FAM108C1 FBF1 FIBP FNDC4 HEY2 HMGCR MADD MAP2K5 NEGR1 NPC1 NT5C2 OLA1 PDIA2 PDXDC2P PMS2P5 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SF3B3 SHISA4 SNRPC STAG3L1 TCTA TNFRSF25 TXNL4B USP36 ZNF668 |
Number of self-reported non-cancer illnesses |
4.70 |
22 |
5 |
11.1 |
0.97 |
1.5e-16 |
AC003029.1 ALDH2 C14orf153 CISD2 CLCN6 CPEB2 FBXO41 FNDC4 FUT2 GMEB2 GPN1 HECTD4 MYO9B NEGR1 PMS2P5 SH2B3 SLC22A1 TCEA2 ZNF318 ZNF652 ZNF831 ZNRF3 |
Miserableness |
1.11 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
ACP2 NR1H3 RP5-1115A15.1 |
Eye problems/disorders: Glaucoma |
1.49 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
DDB2 |
Medication: Blood pressure |
7.86 |
77 |
39 |
86.7 |
0.98 |
6.2e-64 |
AC003029.1 AC006111.1 ACE ACP2 ACTRT3 ADRB1 AGT ALDH2 AP3M1 ARHGAP42 ARID3B ATG7 C11orf1 C15orf17 C1GALT1 C4orf22 CACNB2 CCDC33 CENPW CERS5 CHMP1A CHP1 CLCN6 CMIP CSK CTD-3032J10.3 CTSW CWF19L2 CYB5D1 DBR1 DDB2 FAM108C1 FES GMEB2 GTF2B HECTD4 HOXA10 HOXC8 HRCT1 KB-1107E3.1 LFNG LSP1 MAP3K11 MAPKAPK5 MYO9B NCOA1 NME6 NR1H3 NRBF2 NSUN6 NT5C2 OPRL1 PDXK PIGV PLCB1 PTPRJ RHOC RNASEH2C RNF34 RP11-1055B8.4 RP11-810M2.2 RP4-635E18.7 RPP25 SH2B3 SIPA1 SLC35F6 SLC4A7 TBC1D19 TCEA2 TNFSF12 TNNT3 TPD52L2 ULK3 VEGFB ZNF318 ZNF831 ZNRF3 |
High cholesterol (Self-reported) |
9.10 |
42 |
35 |
77.8 |
0.91 |
3.7e-18 |
ABHD1 AC002558.1 APOB APOC4 ARHGAP42 BCAM C19orf52 DCAF16 DOCK7 EPOR FBF1 FNDC4 FUT2 GCKR GPN1 HMGCR KRTCAP3 LOC100272146 LPL LRPPRC MET NPC1L1 NPEPPS NRBP1 OPRL1 PAFAH1B2 PIGV PPM1G PVRL2 RGL3 RGS12 RPS6 SLC22A1 SORT1 SPC24 TCEA2 TMBIM1 TOMM40 TPD52L2 TXNL4B VEGFB ZNF259 |
Medication: Bendroflumethiazide |
5.07 |
24 |
9 |
20.0 |
0.97 |
5.3e-17 |
ACP2 ADRB1 AGT ARHGAP42 ATP2B1 C15orf17 CACNB2 CD164L2 CHMP1A CSK FAM108C1 FES HOXA10 LSP1 MYO9B NR1H3 PIGV PLCB1 RHOC SLC35F6 SLC4A7 TCF21 TNFSF12 ZNF831 |
Medication: Paracetamol |
1.43 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SDCCAG8 |
Medication: Lisinopril |
3.77 |
6 |
0 |
0.0 |
0.98 |
8.9e-04 |
ARHGAP42 LSP1 NME6 NRBF2 SLC26A6 ZNF831 |
Medication: Atorvastatin |
4.42 |
18 |
12 |
26.7 |
0.98 |
3.0e-14 |
ABHD1 APOB EPOR FNDC4 GCKR GPN1 HMGCR LRPPRC NPEPPS NRBP1 PAFAH1B2 PPM1G PVRL2 SLC22A1 SORT1 SPC24 TOMM40 ZNF259 |
Illnesses of father: High blood pressure |
3.44 |
7 |
1 |
2.2 |
0.99 |
4.4e-05 |
C4orf22 CHMP1A FES NCOA1 NR1H3 PLCB1 UPF3A |
Basal metabolic rate |
2.10 |
44 |
30 |
66.7 |
-0.07 |
6.3e-01 |
AC006547.14 APOC4 C10orf118 CAMK2N2 CENPW CTD-2349P21.5 CTSW DCAF16 EPOR FAM108C1 FIBP FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HEY2 HMGCR MAP2K5 MARCH2 MET NEGR1 NFKBIA NMT1 NPC1 NRBP1 NT5C2 PDE1A PTPRJ RP11-332H18.4 RP11-373D23.3 RP11-613D13.5 SH2B3 SHISA4 SLC35F6 SNRPC STAG3L1 TCTA TMBIM1 UBE2Z UPF3A USP36 ZNF668 |
Leg fat percentage (left) |
2.25 |
33 |
17 |
37.8 |
0.86 |
8.3e-11 |
ACP2 ANKRD13B C14orf153 CHP1 CRK CTB-31O20.6 CTSW DCAF16 DYNC2LI1 FAM108C1 GTF2B HELLS HMGCR MADD MAP2K5 NEGR1 NMT1 NPC1 PDIA2 PDXDC2P PMS2P5 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SHISA4 SIPA1 SNF8 SNRPC STAG3L1 TCTA TNFRSF25 ZNF668 |
Arm fat-free mass (left) |
2.21 |
45 |
27 |
60.0 |
-0.12 |
4.2e-01 |
AC006547.14 ALDH2 APOC4 C10orf118 CENPW CTD-2349P21.5 CTSW DCAF16 EPOR FAM108C1 FIBP FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HEY2 HMGCR MAP2K5 MARCH2 MET NEGR1 NFKBIA NMT1 NPC1 NRBP1 NT5C2 PDE1A PPM1G PTPRJ RP11-332H18.4 RP11-373D23.3 RP11-613D13.5 SH2B3 SHISA4 SLC35F6 SNRPC STAG3L1 TCTA TMBIM1 UBE2Z UPF3A USP36 ZNF668 |
Risk taking |
1.14 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
PCCB SDCCAG8 |
Diastolic blood pressure, automated reading |
7.07 |
102 |
64 |
142.2 |
0.97 |
2.0e-75 |
AC003029.1 AC006111.1 AC091133.1 ACP2 ACTR1B ACTRT3 ADAM1A ADRB1 AGT ALDH2 ARHGAP42 ATP2B1 C10orf118 C14orf153 C15orf17 C1GALT1 C20orf160 C22orf31 C4orf22 CACNB2 CENPW CERS5 CHP1 CLCN6 CLIC4 CLOCK CMIP CSK CTB-31O20.6 CTD-3032J10.3 CTSW CWF19L2 CYB5D1 DCAF16 DDB2 ENPEP FAM108C1 FBXO41 FES FIBP GMEB2 HECTD4 HELLS HOXA10 HRCT1 IPO11 IRAK1BP1 LFNG LOC338758 LSP1 MAP2K5 MAP3K11 MAPKAPK5 MPI MRPS18AP1 MYO9B NAA25 NCOA1 NDUFAF6 NELFCD NME6 NMT1 NOC3L NR1H3 NRBF2 NT5C2 OLA1 PDE1A PDIA2 PIGV PMS2P5 PTPRJ PVRIG RGS19 RHOC RNASEH2C RP11-332H18.4 RP11-463M16.4 RP11-538P18.2 RP5-1115A15.1 RPP25 RYK SDCCAG8 SH2B3 SHISA4 SIPA1 SLC26A6 SNF8 STAG3L1 SWAP70 TCEA2 TCTA TH1L TNFSF12 UBE2Z ULK3 UPF3A USP36 ZC3HC1 ZNF652 ZNF668 ZNF831 |
Myopia |
1.30 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CLOCK |
Vascular/heart problems diagnosed by doctor |
10.82 |
168 |
111 |
246.7 |
-0.99 |
3.2e-169 |
AC002558.1 AC003029.1 AC006111.1 AC006547.14 AC091133.1 ACE ACP2 ACTR1B ACTRT3 ADAM1A ADRB1 AGT AKR1B15 ALDH2 AP3M1 ARHGAP42 ARID3B ATG7 ATP2B1 B3GALT2 C10orf118 C11orf1 C14orf153 C15orf17 C1GALT1 C20orf160 C4orf22 CACNB2 CCDC33 CD164L2 CENPW CEP41 CEP68 CERS5 CHMP1A CHP1 CIRH1A CISD2 CLCN6 CMIP CPEB2 CRK CSK CTB-31O20.6 CTD-3032J10.3 CTSW CWF19L2 CYB5D1 DBR1 DCAF16 DDB2 ENPEP ERAP1 EXOC4 FAM108C1 FBF1 FBXO41 FES FIBP FUT2 GLYR1 GMEB2 GNGT2 GOSR2 GTF2B HECTD4 HOXA10 HOXC8 HRCT1 HSPA4 IPO11 IRAK1BP1 JARID2 KB-1107E3.1 LDB3 LFNG LOC338758 LSP1 MADD MAP2K5 MAP3K11 MAPKAPK5 MARCH2 MET MOBP MPI MRPS18AP1 MXI1 MYO9B NAA25 NADK NCOA1 NDUFAF6 NEGR1 NELFCD NME6 NOC3L NR1H3 NRBF2 NSUN6 NT5C2 NUCB2 OLA1 OPRL1 PCCB PDE1A PDIA2 PDXK PIGV PLCB1 PLEKHM2 PMS2P5 PTPRJ PVRIG RGS19 RHOC RNASEH2C RNF34 RP11-1055B8.4 RP11-332H18.4 RP11-463M16.4 RP11-538P18.2 RP11-613D13.5 RP11-810M2.2 RP4-635E18.7 RP5-1115A15.1 RPP25 RYK SAV1 SDCCAG8 SENP1 SH2B3 SIPA1 SLC22A1 SLC26A10 SLC26A6 SLC35F6 SLC4A7 SNF8 SNX15 SNX16 STAG3L1 SWAP70 TBC1D19 TCEA2 TCF21 TCHP TCTA TH1L THAP9-AS1 THEM6 TNFRSF25 TNFSF12 TNNT3 TPD52L2 TRIM59 TSPY26P UBE2Z ULK3 VANGL1 VEGFB YEATS4 ZC3HC1 ZNF318 ZNF652 ZNF668 ZNF831 ZNRF3 |
Cholesterol lowering medication |
5.67 |
26 |
17 |
37.8 |
0.96 |
6.3e-15 |
APOB BCAM C19orf52 DCAF16 DOCK7 EPOR FNDC4 FUT2 GCKR GPN1 HMGCR LPL NPC1L1 NRBP1 OPRL1 PAFAH1B2 PIGV PVRL2 SORT1 SPC24 TCEA2 TOMM40 TXNL4B VEGFB ZNF259 ZNF668 |
Pain experienced in last month |
1.55 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZNF668 |
Heart attack/myocardial infarction (self-reported) |
2.89 |
9 |
2 |
4.4 |
0.96 |
3.6e-06 |
ANKRD13B FES PCCB SH2B3 SLC22A1 SORT1 SPC24 TCF21 ZNF652 |
Heart disease (siblings) |
1.95 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
FES PVRIG SLC22A1 |
Pack years of smoking |
1.32 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
C14orf153 |
Impedance of whole body |
2.22 |
45 |
26 |
57.8 |
-0.23 |
1.2e-01 |
AC006547.14 C14orf153 CAMK2N2 CCDC33 CENPW CEP41 CERS5 CISD2 CTB-31O20.6 CTD-3032J10.3 CTSW FAM108C1 FIBP FNDC4 GCKR GNGT2 GPN1 HELLS HEY2 HMGCR HOXC8 LSP1 MAP2K5 MARCH2 MYO9B NADK NEGR1 NMT1 NOC3L NT5C2 PCCB PDE1A PDXDC2P PMS2P5 RP11-463M16.4 RP11-613D13.5 RYK SENP1 SHISA4 SNRPC STAG3L1 SWAP70 TNFSF12 ZNF652 ZNF668 |
Leg fat mass (left) |
2.22 |
35 |
20 |
44.4 |
0.80 |
3.9e-09 |
AC091133.1 ACP2 ANKRD13B C14orf153 CTB-31O20.6 CTSW ERAP1 FAM108C1 FIBP FNDC4 HEY2 HMGCR KB-1107E3.1 MADD MAP2K5 MET NEGR1 NPC1 OLA1 PDIA2 PDXDC2P PMS2P5 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SF3B3 SHISA4 SNRPC STAG3L1 TCTA TNFRSF25 TXNL4B USP36 ZNF668 |
Arm predicted mass (left) |
2.23 |
49 |
28 |
62.2 |
-0.12 |
3.9e-01 |
AC006547.14 ALDH2 APOC4 C10orf118 CAMK2N2 CENPW CMIP CTD-2349P21.5 DCAF16 EPOR FAM108C1 FIBP FNDC4 GATAD1 GCKR GLYR1 GPN1 HECTD4 HEY2 HMGCR MAP2K5 MAPKAPK5 MARCH2 MET NCOA1 NEGR1 NFKBIA NMT1 NPC1 NRBP1 NT5C2 PDE1A PPM1G PTPRJ RP11-332H18.4 RP11-373D23.3 RP11-613D13.5 SH2B3 SHISA4 SLC35F6 SNRPC SORT1 STAG3L1 TCTA TMBIM1 UBE2Z UPF3A USP36 ZNF668 |